Insider Transactions in Q3 2024 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
847
-0.67%
|
$13,552
$16.0 P/Share
|
|
Sep 09
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,195
-4.01%
|
$44,730
$14.97 P/Share
|
|
Sep 09
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
2,642
-1.42%
|
$39,630
$15.09 P/Share
|
|
Sep 09
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
1,904
-1.49%
|
$28,560
$15.07 P/Share
|
|
Sep 06
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
600
-0.32%
|
$9,000
$15.24 P/Share
|
|
Sep 06
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
399
-0.31%
|
$5,985
$15.19 P/Share
|
|
Sep 05
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-0.21%
|
$2,475
$15.13 P/Share
|
|
Sep 05
2024
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
826
-0.25%
|
$12,390
$15.13 P/Share
|
|
Sep 05
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
167
-0.09%
|
$2,505
$15.13 P/Share
|
|
Sep 05
2024
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-0.13%
|
$2,565
$15.13 P/Share
|
|
Sep 04
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
941
-1.16%
|
$14,115
$15.42 P/Share
|
|
Sep 04
2024
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,744
-1.43%
|
$71,160
$15.42 P/Share
|
|
Sep 04
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
955
-0.51%
|
$14,325
$15.42 P/Share
|
|
Sep 04
2024
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
983
-0.76%
|
$14,745
$15.42 P/Share
|
|
Sep 03
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
625
-0.26%
|
$10,000
$16.8 P/Share
|
|
Sep 03
2024
|
Dipal Doshi CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,152
-0.31%
|
$50,432
$16.8 P/Share
|
|
Sep 03
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-0.11%
|
$10,144
$16.8 P/Share
|
|
Sep 03
2024
|
Nathan J Dowden President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
654
-0.17%
|
$10,464
$16.8 P/Share
|
|
Aug 16
2024
|
Nathan J Dowden President & COO |
SELL
Open market or private sale
|
Direct |
27,097
-8.65%
|
$433,552
$16.48 P/Share
|
|
Aug 16
2024
|
Nathan J Dowden President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+11.29%
|
$20,000
$1.74 P/Share
|
|
Jul 15
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,600
-0.48%
|
$27,200
$17.81 P/Share
|
|
Jul 15
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
638
-0.34%
|
$11,484
$18.0 P/Share
|
|
Jul 12
2024
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
300
-0.09%
|
$5,400
$18.0 P/Share
|
|
Jul 12
2024
|
Natarajan Sethuraman President, Research & Develop. |
SELL
Open market or private sale
|
Direct |
600
-0.32%
|
$10,800
$18.0 P/Share
|
|
Jul 08
2024
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,758
-2.11%
|
$24,612
$14.95 P/Share
|